G. Fürstenberger

发表

Circulating endothelial cells and angiogenic serum factors during neoadjuvant chemotherapy of primary breast cancer

B. Thürlimann, H. Senn, R. Lucas, 2006, British Journal of Cancer.

Bevacizumab specifically decreases elevated levels of circulating KIT+CD11b+ cells and IL-10 in metastatic breast cancer patients

S. Pradervand, T. Ruhstaller, C. Rüegg, 2016, Oncotarget.

Soluble CD146 is generated by ectodomain shedding of membrane CD146 in a calcium-induced, matrix metalloprotease-dependent process.

D. Legler, H. Illges, G. Fürstenberger, 2009, Microvascular research.

Insulin-like growth factors and cancer.

H. Senn, Hans-Jörg Senn, Gregor Fürstenberger, 2002, The Lancet. Oncology.

Real-time PCR of CD146 mRNA in peripheral blood enables the relative quantification of circulating endothelial cells and is an indicator of angiogenesis

H. Senn, G. Fürstenberger, E. Boneberg, 2005, British Journal of Cancer.

The process of metastasisation for breast cancer.

D Hölzel, H. Senn, J. Engel, 2003, European journal of cancer.

Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancer.

M. Groettrup, P. Diener, U. Schmid, 2000, Cancer research.

Reduced expression of cyclooxygenase-2 in primary breast cancer.

H. Senn, D. Legler, G. Fürstenberger, 2008, Journal of the National Cancer Institute.

Angiogenesis and lymphangiogenesis are downregulated in primary breast cancer

H. Senn, H. Steininger, L. Füzesi, 2009, British Journal of Cancer.

Insulin-Like Growth Factors and Breast Cancer

H. Senn, R. Morant, G. Fürstenberger, 2003, Oncology Research and Treatment.

Serum levels of IGF-1 and IGFBP-3 during adjuvant chemotherapy for primary breast cancer.

H. Senn, R. Morant, B. Bolliger, 2003, Breast.